Recursion Pharmaceuticals, Inc. (RXRX) Ownership

$4.18

$0.27 (-6.07%)
Last update: 04:00 PM EST
Day's range
$4.11
Day's range
$4.36

Recursion Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ARK INVESTMENT MANAGEMENT LLC 05/07/2025 34.82 M $184.17 M   7.63% 8.64%
VANGUARD GROUP INC 05/09/2025 32.29 M $170.80 M   -5.06% 8.02%
BAILLIE GIFFORD & CO 05/07/2025 24.39 M $129.04 M   -1.89% 6.06%
BLACKROCK, INC. 05/02/2025 23.51 M $124.35 M   0.30% 5.84%
SOFTBANK GROUP CORP. 05/15/2025 14.67 M $77.59 M   0.00% 3.64%
KINNEVIK AB (PUBL) 04/28/2025 13.43 M $71.07 M   12.84% 3.34%
STATE STREET CORP 05/15/2025 13.09 M $69.22 M   4.03% 3.25%
MUBADALA INVESTMENT CO PJSC 05/15/2025 12.99 M $68.70 M   0.00% 3.22%
NOVO HOLDINGS A/S 05/15/2025 9.67 M $51.13 M   -4.44% 2.40%
MIC CAPITAL MANAGEMENT UK LLP 05/15/2025 9.64 M $51.02 B   0.00% 2.39%
SUMITOMO MITSUI TRUST HOLDINGS, INC. 04/25/2025 8.48 M $44.86 M   -5.58% 2.11%
NIKKO ASSET MANAGEMENT AMERICAS, INC. 05/07/2025 8.41 M $44.39 M   -5.63% 2.09%
NVIDIA CORP 05/15/2025 7.71 M $40.77 M   0.00% 1.91%
FMR LLC 05/12/2025 6.85 M $36.22 M   -3.19% 1.70%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 6.44 M $34.10 M   5.86% 1.60%
UBS ASSET MANAGEMENT AMERICAS INC 05/19/2025 6.41 M $33.90 M   183.67% 1.59%
DATA COLLECTIVE IV GP, LLC 05/15/2025 5.94 M $31.43 B   0.00% 1.48%
MORGAN STANLEY 05/15/2025 5.01 M $26.51 M   75.16% 1.24%
DCVC OPPORTUNITY FUND II GP, LLC 05/15/2025 3.95 M $20.90 M   0.00% 0.98%
EXOR CAPITAL LLP 05/15/2025 3.68 M $19.44 M   0.00% 0.91%
CITADEL ADVISORS LLC 05/15/2025 2.66 M $14.05 M   -3.05% 0.66%
NORTHERN TRUST CORP 05/13/2025 2.40 M $12.67 M   0.03% 0.59%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 2.28 M $12.05 M   0.19% 0.57%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 2.05 M $10.84 M   22.95% 0.51%
05/12/2025 1.91 M $10.12 M   100.00% 0.47%
DIMENSIONAL FUND ADVISORS LP 05/13/2025 1.72 M $9.09 M   0.51% 0.43%
LAURION CAPITAL MANAGEMENT LP 05/15/2025 1.55 M $8.19 M   -37.03% 0.38%
GOLDMAN SACHS GROUP INC 05/16/2025 1.50 M $7.91 M   -27.57% 0.37%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 1.42 M $7.53 M   43.47% 0.35%
CITADEL ADVISORS LLC 05/15/2025 1.36 M $7.19 M   3.90% 0.34%
BANK OF AMERICA CORP /DE/ 05/15/2025 1.28 M $6.80 M   45.54% 0.32%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 1.16 M $6.16 M   1.66% 0.29%
TWO SIGMA INVESTMENTS, LP 05/15/2025 1.15 M $6.10 M   -30.59% 0.29%
FIRST TRUST ADVISORS LP 05/14/2025 1.03 M $5.46 M   100.00% 0.26%
COMPREHENSIVE FINANCIAL MANAGEMENT LLC 05/15/2025 941.90 K $4.98 M   0.00% 0.23%
BANK OF NEW YORK MELLON CORP 04/29/2025 863.22 K $4.57 M   1.48% 0.21%
JPMORGAN CHASE & CO 05/12/2025 818.32 K $4.33 M   -22.59% 0.20%
VESTMARK ADVISORY SOLUTIONS, INC. 05/13/2025 706.24 K $3.74 M   -16.44% 0.18%
05/15/2025 698.40 K $3.69 M   132.80% 0.17%
NAN FUNG GROUP HOLDINGS LTD 05/14/2025 664.61 K $3.52 M   0.00% 0.17%
CITIGROUP INC 05/12/2025 659.45 K $3.49 M   31.63% 0.16%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2025 652.64 K $3.45 M   100.00% 0.16%
WELLS FARGO & COMPANY/MN 05/13/2025 603.73 K $3.19 M   31.73% 0.15%
RAFFERTY ASSET MANAGEMENT, LLC 05/14/2025 598.42 K $3.17 M   0.50% 0.15%
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC 05/14/2025 595.52 K $3.15 M   0.00% 0.15%
LIONTRUST INVESTMENT PARTNERS LLP 05/13/2025 595.06 K $3.15 M   -36.13% 0.15%
JUMP FINANCIAL, LLC 05/14/2025 592.35 K $3.13 M   4,289.75% 0.15%
BARCLAYS PLC 05/15/2025 591.01 K $3.13 M   -6.65% 0.15%
LAZARD ASSET MANAGEMENT LLC 05/15/2025 506.14 K $2.68 M   -8.94% 0.13%
MILLENNIUM MANAGEMENT LLC 05/15/2025 502.11 K $2.66 M   1,673.61% 0.12%

Recursion Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 372 institutional investors and hedge funds held shares of Recursion Pharmaceuticals, Inc.. The most heavily invested institutionals were:

ARK Investment Management LLC: 34.82 M

VANGUARD GROUP INC: 32.29 M

BAILLIE GIFFORD & CO: 24.39 M

BlackRock, Inc.: 23.51 M

SOFTBANK GROUP CORP.: 14.67 M

Kinnevik AB (publ): 13.43 M

75.54% of Recursion Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 327.57 M shares in the last 24 months. This purchase volume represents approximately $1.37 B in transactions.